ADBiotech Co., Ltd. (KOSDAQ: 179530)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,710.00
+85.00 (3.24%)
Dec 19, 2024, 2:09 PM KST

ADBiotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
23,12529,93530,71245,09237,494
Market Cap Growth
1.01%-2.53%-31.89%20.26%-
Enterprise Value
31,44339,45935,18349,488-
Last Close Price
2530.003275.003360.009100.007566.67
PE Ratio
--11.39--
PS Ratio
2.632.862.893.813.82
PB Ratio
5.232.381.908.834.02
P/TBV Ratio
13.742.661.908.844.02
P/FCF Ratio
-398.99---
P/OCF Ratio
-95.05---
EV/Sales Ratio
3.573.773.314.18-
EV/FCF Ratio
-91.85525.92---
Debt / Equity Ratio
3.571.080.792.580.78
Debt / FCF Ratio
-181.40---
Asset Turnover
0.340.350.410.59-
Inventory Turnover
2.182.792.973.52-
Quick Ratio
0.220.980.890.500.90
Current Ratio
0.511.191.200.691.32
Return on Equity (ROE)
-122.00%-37.78%25.33%-36.92%-
Return on Assets (ROA)
-10.70%-10.09%-11.98%-4.88%-
Return on Capital (ROIC)
-12.93%-10.82%-13.19%-5.58%-
Earnings Yield
-36.68%-9.57%8.78%-5.91%-19.59%
FCF Yield
-1.48%0.25%-30.34%-12.74%-16.83%
Buyback Yield / Dilution
9.99%9.33%-31.17%-53.77%-
Total Shareholder Return
9.99%9.33%-31.17%-53.77%-
Source: S&P Capital IQ. Standard template. Financial Sources.